Stuart Therapeutics
Focus: Stuart Therapeutics is a public biotechnology company founded in 2018 focused on chronic ophthalmology treatments, headquartered in Stuart, Florida. The company operates as a small-scale biotech with a marketed product and early-to-mid stage pipeline across ophthalmology and select other indications.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Stuart Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Stuart Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
LOE Approaching
Only marketed product; loss of exclusivity timeline unknown but creates urgent revenue pressure without disclosed replacement revenue.
Products & Portfolio (1)
Help build intelligence for Stuart Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.